Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.

SHSE:603168 Stock Report

Market Cap: CN¥3.0b

Zhejiang Shapuaisi PharmaceuticalLtd Balance Sheet Health

Financial Health criteria checks 4/6

Zhejiang Shapuaisi PharmaceuticalLtd has a total shareholder equity of CN¥1.7B and total debt of CN¥205.7M, which brings its debt-to-equity ratio to 12.2%. Its total assets and total liabilities are CN¥2.1B and CN¥431.3M respectively.

Key information

12.2%

Debt to equity ratio

CN¥205.68m

Debt

Interest coverage ration/a
CashCN¥198.96m
EquityCN¥1.69b
Total liabilitiesCN¥431.28m
Total assetsCN¥2.12b

Recent financial health updates

No updates

Recent updates

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (SHSE:603168) Investors Are Less Pessimistic Than Expected

Aug 23
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (SHSE:603168) Investors Are Less Pessimistic Than Expected

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.'s (SHSE:603168) Shares May Have Run Too Fast Too Soon

Apr 09
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.'s (SHSE:603168) Shares May Have Run Too Fast Too Soon

Financial Position Analysis

Short Term Liabilities: 603168's short term assets (CN¥401.0M) exceed its short term liabilities (CN¥305.6M).

Long Term Liabilities: 603168's short term assets (CN¥401.0M) exceed its long term liabilities (CN¥125.7M).


Debt to Equity History and Analysis

Debt Level: 603168's net debt to equity ratio (0.4%) is considered satisfactory.

Reducing Debt: 603168's debt to equity ratio has increased from 0% to 12.2% over the past 5 years.

Debt Coverage: 603168's debt is well covered by operating cash flow (28.4%).

Interest Coverage: Insufficient data to determine if 603168's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies